Literature DB >> 12230030

What's in a name? A systematic review of the nomenclature of Chinese medical formulae.

Jongbae Park1, Hi-Joon Park, Hye-Jung Lee, Edzard Emst.   

Abstract

Traditional Chinese Medicine (TCM) has been modified to some extent in other Far Eastern countries such as Korea and Japan. Researchers of each of the three countries seem to use different English names for the same Chinese medicinal formulae. Lack of knowledge of the Chinese characters is destined to increase this confusion. In order to investigate this matter systematically, all investigations of Chinese medicine formulae published in the American Journal of Chinese Medicine (AJCM, 1997-March 2001) were evaluated. Moreover, PubMed (1966-June 2001) was searched using keywords differentiated by language, location and number of hyphens, and upper-or lower-case of the first letter of the English equivalent of each Chinese character. Fifty-four formulae of TCM were identified in 45 reports published in AJCM. Thirty-two were named in Chinese only (23 reports); six in Japanese (six reports); and five in Korean (five reports). Ten formulae were named in Japanese with the Chinese name in brackets (ten reports); and one in Chinese with the Japanese name in brackets (one report). By computerized literature search, different numbers of research papers were retrieved by using keywords differentiated by language, location and number of hyphens. Such confusion may prevent progress in the evaluation of TCM. To increase the efficiency of studies on Chinese medical formulae, standardization of terminology is required.

Mesh:

Substances:

Year:  2002        PMID: 12230030     DOI: 10.1142/S0192415X02000430

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  The reporting quality, scientific rigor, and ethics of randomized placebo-controlled trials of traditional Chinese medicine compound formulations and the differences between Chinese and non-Chinese trials.

Authors:  Yun-Qing Zhong; Juan-Juan Fu; Xue-Mei Liu; Xiang Diao; Bing Mao; Tao Fan; Hong-Mei Yang; Guan-Jian Liu; Wen-Bin Zhang
Journal:  Curr Ther Res Clin Exp       Date:  2010-02

2.  Effect of Guizhifulingwan (Keishibukuryogan) on climacteric syndrome: study protocol for a randomized controlled pilot trial.

Authors:  Jung-Eun Kim; Junghyo Cho; Ojin Kwon; Ae-Ran Kim; Hyo-Ju Park; So-Young Jung; Joo-Hee Kim; Mikyung Kim; Hye-Yoon Lee; Jun-Hwan Lee
Journal:  Trials       Date:  2017-03-21       Impact factor: 2.279

3.  An Overview of Traditional Chinese Herbal Formulae and a Proposal of a New Code System for Expressing the Formula Titles.

Authors:  Yeong-Deug Yi; Il-Moo Chang
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.